These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

763 related items for PubMed ID: 16678904

  • 1. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care.
    Khare MD, Bukhari SS, Swann A, Spiers P, McLaren I, Myers J.
    J Infect; 2007 Feb; 54(2):146-50. PubMed ID: 16678904
    [Abstract] [Full Text] [Related]

  • 2. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K, Zenz S, Jüttner B, Ruschulte H, Kuse E, Heine J, Piepenbrock S, Ganser A, Karthaus M.
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [Abstract] [Full Text] [Related]

  • 3. [Assessment of diagnostic methods for the catheter-related bloodstream infections in intensive care units].
    Ataman Hatipoğlu C, Ipekkan K, Oral B, Onde U, Bulut C, Demiröz AP.
    Mikrobiyol Bul; 2011 Jan; 45(1):75-85. PubMed ID: 21341162
    [Abstract] [Full Text] [Related]

  • 4. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, Lherm T, Santoli F, Naija W, Riou B.
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [Abstract] [Full Text] [Related]

  • 5. Central venous catheter-associated bloodstream infection and colonisation of insertion site and catheter tip. What are the rates and risk factors in haematology patients?
    Luft D, Schmoor C, Wilson C, Widmer AF, Bertz H, Frei R, Heim D, Dettenkofer M.
    Ann Hematol; 2010 Dec; 89(12):1265-75. PubMed ID: 20532506
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of interventions to reduce catheter-associated bloodstream infection: continuous tailored education versus one basic lecture.
    Lobo RD, Levin AS, Oliveira MS, Gomes LM, Gobara S, Park M, Figueiredo VB, de Vasconcelos Santos E, Costa SF.
    Am J Infect Control; 2010 Aug; 38(6):440-8. PubMed ID: 20123149
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D, Catheter-Related Infections in ICU (CRI-ICU) Group.
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [Abstract] [Full Text] [Related]

  • 8. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF, Marra AR, Büchele GL, Sogayar AM, Cal RG, de Sousa JM, Silva E, Knobel E, Edmond MB.
    J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
    [Abstract] [Full Text] [Related]

  • 9. Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units.
    Gunst M, Matsushima K, Vanek S, Gunst R, Shafi S, Frankel H.
    Surg Infect (Larchmt); 2011 Aug; 12(4):279-82. PubMed ID: 20629557
    [Abstract] [Full Text] [Related]

  • 10. Bloodstream infection related to catheter connections: a prospective trial of two connection systems.
    Esteve F, Pujol M, Limón E, Saballs M, Argerich MJ, Verdaguer R, Mañez R, Ariza X, Gudiol F.
    J Hosp Infect; 2007 Sep; 67(1):30-4. PubMed ID: 17719682
    [Abstract] [Full Text] [Related]

  • 11. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ, Zack JE, Thomas J, Borecki IB, Sona CS, Schallom ME, Venker M, Nemeth JL, Ward MR, Verjan L, Warren DK, Fraser VJ, Mazuski JE, Boyle WA, Buchman TG, Coopersmith CM.
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [Abstract] [Full Text] [Related]

  • 12. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
    Osma S, Kahveci SF, Kaya FN, Akalin H, Ozakin C, Yilmaz E, Kutlay O.
    J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
    [Abstract] [Full Text] [Related]

  • 14. Development of bacteraemia or fungaemia after removal of colonized central venous catheters in patients with negative concomitant blood cultures.
    Park KH, Kim SH, Song EH, Jang EY, Lee EJ, Chong YP, Choi SH, Lee SO, Woo JH, Kim YS.
    Clin Microbiol Infect; 2010 Jun; 16(6):742-6. PubMed ID: 19747217
    [Abstract] [Full Text] [Related]

  • 15. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G.
    N Engl J Med; 1999 Jan 07; 340(1):1-8. PubMed ID: 9878638
    [Abstract] [Full Text] [Related]

  • 16. Catheter-associated bloodstream infections: looking outside of the ICU.
    Marschall J.
    Am J Infect Control; 2008 Dec 07; 36(10):S172.e5-8. PubMed ID: 19084150
    [Abstract] [Full Text] [Related]

  • 17. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
    Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EA.
    J Antimicrob Chemother; 2004 Dec 07; 54(6):1109-15. PubMed ID: 15537696
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.